BMP2 and metabolic dysfunction-associated steatotic liver disease: A novel finding of the present study is that BMP2 expression is increased in the liver from NAFLD patients as well as that serum BMP2 levels were also higher in these patients than in subjects with histologically normal liver, positioning this protein as a new molecular target linked to NAFLD.